当前位置: 首页 > 期刊 > 《中国现代医生》 > 2011年第34期 > 正文
编号:12144650
96例胃癌患者血清肿瘤标记物联合检测的临床分析(3)
http://www.100md.com 2011年12月5日 汪光云 陈敏方
第1页

    参见附件(2929KB,3页)。

     [6] Yamamoto M,Baba H,Toh Y,et al.Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients[J].J Cancer Res Clin Oneol,2007,133(7):471-473.

    [7] Canil CM,Tannock IF. Doctor's dilemma:incorporating tumor markers into clinical decision-marking[J]. Semin Oncol,2002,29(3):286-293.

    [8] Walsh TN,Grannell M,Mansoor S. Predictive factors for success of neo-adjuvant therapy in upper gastrointestinal cancer[J]. J Gastroenterol Hepatol,2002,17(3):172-175.

    [9] Benbehani AL,Mahew A,Farghaly M,et al. Reference levels of the tumor markers carcinoembryonic antigen,the carbohydrate antigens 19-9 and 72-4,and cytokeratin fragment 19 using the Elecsys Relecsys 1010 analyzer in a normal population in Kuwait. The importance of the determination of local reference levels[J]. Int J Biol Markers,2002,17(1):67-70.

    [10] Cui JH,Krueger U,Henne-Brune D,et al. Orthotopic transplantation model of human gastrointestinal cancer and detection of micrometastases[J]. World J Gastroenterol,2001,7(3):381-386.

    (收稿日期:2011-09-22)

您现在查看是摘要介绍页,详见PDF附件(2929KB,3页)